Volato Group, Inc. (SOAR) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Volato Group, Inc. on June 18, 2026. The filing reports the closing of a previously announced Private Placement and an amendment to a Registration Rights Agreement.
Key Financial Metrics
- Capital Raised: Gross proceeds of approximately $2.21 million were received upon the closing of the Private Placement.
- Transaction Details: The Company issued 6,500,000 shares of Class A common stock at a price of $0.34 per share.
- Investors: The securities were sold to Catheter Precision, Inc. (NYSE American: VTAK) and certain institutional investors.
- Other Metrics: The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity beyond the proceeds from this specific transaction.
Material Changes
The primary material change is the successful closing of the Private Placement on June 18, 2026, resulting in an increase in outstanding shares and cash assets. Additionally, the Company executed Amendment No. 1 to the Registration Rights Agreement, extending the deadline to file a registration statement for the resale of the shares to 5:30 p.m. Eastern Time on June 18, 2026.
Outlook, Risks, and Contingencies
The filing includes standard forward-looking statements regarding the Company's growth strategy and service delivery. Specific risks highlighted include:
- The possibility that a Reverse Stock Split may not increase the trading price of the Common Stock.
- The risk of failing to maintain compliance with continued listing requirements.
- General economic, competitive, and regulatory factors beyond the Company's control.
The Company disclaims any obligation to update forward-looking statements except as required by law.
Key Facts for Investor Verification
- Verify the final net proceeds after deducting transaction fees and offering expenses, as only gross proceeds ($2.21 million) are stated.
- Confirm the filing status of the registration statement for the resale of the 6,500,000 shares, which was due by June 18, 2026.
- Review the full text of the Purchase Agreement and Registration Rights Agreement (Exhibits 10.1 to Prior 8-K and 10.1 to this 8-K) for restrictive covenants.
- Monitor the Company's compliance with NYSE American listing requirements, specifically regarding the Reverse Stock Split mentioned in the risk factors.